Integrative Clinical Treatment of Grade II Soft Tissue Sarcoma with Homeopathic Mistletoe and Associations: Case Report
Journal: Journal of Pharmacy and Pharmacology (Vol.10, No. 2)Publication Date: 2022-02-02
Authors : Daniela Franco Lopes Ana Claudia de Benedictis Andreta; Rafael Franchi Traldi;
Page : 55-61
Keywords : Mistletoe ultra-diluted; homeopathy; dog; neoplasm; soft sarcoma.;
Abstract
The centenary use of the Hippocratic era, the semi parasitic plant Mistletoe (Viscum album L.) from the Santalaceae family, has been used to improve immunity and staging of several tumor diseases, proving to be a biological agent in integrative medicine that promotes quality of life and presents antitumor activity by cytotoxicity, induction of apoptosis and inhibition of angiogenesis. Type II soft tissue sarcomas are rarer in animals than in humans, although the multimodal treatment of surgery-chemotherapy is elected, it is still not well established and has not increased survival, so we opted for the use of homeopathic mistletoe and nutraceuticals as integrative treatment. The aim of the present report was to describe the evolution and clinical staging of a Labrador retriever, which received Mistletoe (Ultra diluted Viscum album) in combination with natural food and acupuncture. We conclude that the combined use of homeopathic integrative mistletoe ultra-diluted therapies in this patient promoted the control and staging of the sarcoma, improved immunity and quality of life, clinical and laboratory side effects during the effect period of 58 months.
Other Latest Articles
- Influence of Chemostimulation of Different Nuclei of the Amygdala on the Implementation of the Drinking Conditioned Reflex
- Glucose-6-Phosphate Dehydrogenase Deficiency and Malaria Infections in Brazil
- Biflavanoids from Semecarpus Anacardum L.f., Their Biological Aspects and Docking Studies
- Formulation and Evaluation of Natural Herbal Hair Dye Gel Using Lawsonia inermis (Henna Leaves) and Skin Irritation Studies in Albino Rats
- Adult Onset X-Linked Adrenoleukodystrophy Frontal Variant – A Case Report
Last modified: 2022-03-29 11:14:25